Categories
Coronavirus

Short Term Insurance Market Insights 2020-2025 | UnitedHealthcare, State Farm, The IHC Group, OUTsurance

Short Term Insurance Market has been riding a progressive growth trail over the recent past. The first two quarters of the year 2020 have however witnessed heavy disruptions throughout all the industry facets, which are ultimately posing an unprecedented impact on Short Term Insurance market. Although healthcare & life sciences industry as a whole is witnessing an influx of opportunities in selected sectors, it remains a matter of fact that some of the industry sectors have temporarily scaled back. It becomes imperative to stay abreast of all the recent updates and predict the near future wisely.

The Global Short Term Insurance Market is gaining pace and businesses have started understanding the benefits of analytics in the present day highly dynamic business environment. The market has witnessed several important developments over the past few years, with mounting volumes of business data and the shift from traditional data analysis platforms to self-service business analytics being some of the most prominent ones.

“Our analysis involves the study of the market taking into consideration the impact of the COVID-19 pandemic. Please get in touch with us to get your hands on an exhaustive coverage of the impact of the current situation on the market. Our expert team of analysts will provide as per report customized to your requirement.”

Request a sample of this premium research: https://www.bigmarketresearch.com/request-sample/3568485?utm_source=GEETA/PRL

Top Key Players involved in Short Term Insurance Industry are:
UnitedHealthcare, State Farm, The IHC Group, OUTsurance, PSG Konsult Ltd, National General, SBI Holdings, Aviva, Cuvva, National Health Insurance Company, Chubb, VIVA VIDA, Santam, CPIC, Liberty Mutual, USAA, Aeon Life, AIG, Lidwala Insurance

Global Short Term Insurance market is presented to the readers as a holistic snapshot of the competitive landscape within the given forecast period. It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of where areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.

For the future period, sound forecasts on market value and volume are offered for each type and application. In the same period, the report also provides a detailed analysis of market value and consumption for each region. These insights are helpful in devising strategies for the future and take necessary steps. New project investment feasibility analysis and SWOT analysis are offered along with insights on industry barriers. Research findings and conclusions are mentioned at the end.

Regions & Top Countries Data Covered in this Report are: Asia-Pacific (China, Southeast Asia, India, Japan, Korea, Western Asia), Europe (Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland), North America (United States, Canada, Mexico), Middle East & Africa (GCC, North Africa, South Africa) , South America (Brazil, Argentina, Columbia, Chile, Peru).

Segmentation by Type:
Homeowner Insurance, Household Insurance, Vehicle Insurance, Personal Liability Insurance, Others

Impact of Covid-19 in Short Term Insurance  Market: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Short Term Insurance  market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Points Covered in the Report:

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.

• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Flat 10% Discount on this Research Report @ https://www.bigmarketresearch.com/checkout/sales/7408?utm_source=PRL&utm_medium=ORG131GB

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact us:

Mr. Abhishek Paliwal

5933 NE Win Sivers Drive, #205, Portland,

OR 97220 United States

Direct: +1-971-202-1575

Toll Free: +1-800-910-6452

E-mail: [email protected]

 

 

 

Categories
Coronavirus

Data Center Backup and Recovery Software Market Is Booming Global |Commvault Systems Inc., Veeam Software Group GmbH, Dell Technologies Inc.

Data Center Backup and Recovery Software Market has been riding a progressive growth trail over the recent past. The first two quarters of the year 2020 have however witnessed heavy disruptions throughout all the industry facets, which are ultimately posing an unprecedented impact on Data Center Backup and Recovery Software market. Although healthcare & life sciences industry as a whole is witnessing an influx of opportunities in selected sectors, it remains a matter of fact that some of the industry sectors have temporarily scaled back. It becomes imperative to stay abreast of all the recent updates and predict the near future wisely.

The Global Data Center Backup and Recovery Software Market is gaining pace and businesses have started understanding the benefits of analytics in the present day highly dynamic business environment. The market has witnessed several important developments over the past few years, with mounting volumes of business data and the shift from traditional data analysis platforms to self-service business analytics being some of the most prominent ones.

“Our analysis involves the study of the market taking into consideration the impact of the COVID-19 pandemic. Please get in touch with us to get your hands on an exhaustive coverage of the impact of the current situation on the market. Our expert team of analysts will provide as per report customized to your requirement.”

Request a sample of this premium research: https://www.bigmarketresearch.com/request-sample/3568484?utm_source=GEETA/PRL

Top Key Players involved in Data Center Backup and Recovery Software Industry are:
Commvault Systems Inc., Veeam Software Group GmbH, Dell Technologies Inc., IBM Corp., Veritas Technologies LLC.

Global Data Center Backup and Recovery Software market is presented to the readers as a holistic snapshot of the competitive landscape within the given forecast period. It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of where areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.

For the future period, sound forecasts on market value and volume are offered for each type and application. In the same period, the report also provides a detailed analysis of market value and consumption for each region. These insights are helpful in devising strategies for the future and take necessary steps. New project investment feasibility analysis and SWOT analysis are offered along with insights on industry barriers. Research findings and conclusions are mentioned at the end.

Regions & Top Countries Data Covered in this Report are: Asia-Pacific (China, Southeast Asia, India, Japan, Korea, Western Asia), Europe (Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland), North America (United States, Canada, Mexico), Middle East & Africa (GCC, North Africa, South Africa) , South America (Brazil, Argentina, Columbia, Chile, Peru).

Segmentation by Type:
Data Center Backup, Data Center Recovery

Impact of Covid-19 in Data Center Backup and Recovery Software  Market: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Data Center Backup and Recovery Software  market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Points Covered in the Report:

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.

• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Flat 10% Discount on this Research Report @ https://www.bigmarketresearch.com/checkout/sales/7407?utm_source=PRL&utm_medium=ORG131GB

About Us:

Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.

We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact us:

Mr. Abhishek Paliwal

5933 NE Win Sivers Drive, #205, Portland,

OR 97220 United States

Direct: +1-971-202-1575

Toll Free: +1-800-910-6452

E-mail: [email protected]

 

 

 

Categories
Coronavirus News

Health Caregiving Market To Register CAGR 12.6% Growth In Revenue Between 2024

Market Report Summary 

  • Market – Health Caregiving Market 
  • Market Value – US$ 200 Bn in 2024 
  • Market CAGR Value – 12.6% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

Noble services offered by caregivers from around the world continue to nurture the fragile health of elderlies as well as the blooming lives of infants. Demand for health caregiving services will continue to surge in the years to come as people will keep appointing professional help for nursing the health of their loved ones. By now, the global market for health caregiving has evolved into a key aspect of the world’s medical services sector.

After raking in more than US$ 75 billion revenues in 2015, the global health caregiving market fared well to reach market valuation of an estimated US$ 84.5 billion in 2016. According to a recent study conducted by Persistence Market Research, global health caregiving revenues will continue to increase at an impressive CAGR of 12.6%, reaching US$ 218,469 million by the end of 2024.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12865

Company Profile

  • Honor Technology, Inc.
  • Hometeam Care, Inc.
  • HomeHero, Inc.
  • Seniorlink, Inc.
  • GreatCall, Inc.
  • Cariloop, Inc.
  • Room2Care, Ltd.
  • UnaliWear, Inc.
  • Care.com, Inc.
  • CareLinx, Inc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12865

Persistence Market Research’s report, titled “Health Caregiving Market: Global Industry Analysis & Forecast, 2016-2024,” estimates that increasing presence of nuclear families, that were instrumented by the popularity of “DINK” trend (Double Income, No Kids), has turned out to be a key factor driving the demand for health caregiving services. These services are being used for taking care of toddlers in families with both parents working, while consanguineal or extended families are also opting for health caregivers to take care of their aged family members at home.

Surging Demand for Health Caregiving on Daily Basis

Assistance in daily essential activities can be clubbed up to be identified as a key type of health caregiving service being utilized in the world. According to the report, nearly three-fourth of global health caregiving revenues will continue to be accounted by services availed for seeking assistance in daily essential activities. Meanwhile, health caregiving services that provide health & safety awareness and improve “quality of life” are anticipated to contribute more than US$ 30 billion worth of global revenues by the end of 2024.

However, health caregiving services availed for social well-being will continue to lose traction in 2016 and beyond, registering a revenue growth at the lowest CAGR – 11.9%.

Aged People – World’s Largest End-user of Health Caregiving Services

A segmental analysis of global health caregiving market on the basis of end-users has predicted that by the end of 2024, geriatric population will account for nearly one-third of the global market revenues.

The world’s disabled population will be attributing to global health caregiving revenues worth over US$ 50 billion over the forecast period. In 2016, more than US$ 16 billion revenues were amassed from health caregiving services availed for neonatal & pediatric population, rendering infants and toddlers as prominent end-users of health caregiving services.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12865

Regional Overview of Global Health Caregiving Market

  • North America is predicted to be the world’s largest market for health caregiving services. In 2016 and beyond, North America will contribute with more than 50% of global revenues, registering a 15.3% CAGR.
  • Companies such as Seniorlink, Inc., GreatCall, UnaliWear Inc., Cariloop, Inc., HomeHero Inc., Hometeam, and Honor Technology Inc., are leading providers of health caregiving services in the world, and are all based in the US.
  • Asia-Pacific’s health caregiving market is being forecasted to reach market value of an estimated US$ 14,756.3 million by the end of 2024.
  • Demand for health caregiving services in Latin America and the Middle East & Africa (MEA) region is projected to grow at a comparatively sluggish pace.
  • Europe, on the other hand, is likely to be the fastest-growing regional market for health caregiving services during the forecast period.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

The Uveitis Market To Go Strong With 6.5% CAGR Between 2024

Market Report Summary 

  • Market – Uveitis Market 
  • Market Value – US$ 840 Mn in 2024 
  • Market CAGR Value – 6.5% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

The US$ 497 Mn uveitis treatment market is likely to expand at a stable CAGR of 6.5% over the next eight years. In 2017, the market is expected to witness nearly 6.7% Y-o-Y growth over 2016. During 2016-2024, Persistence Market Research predicts a positive growth outlook for the global uveitis treatment market, influenced by several growth drivers, restraints, trends, and opportunities.

In its recently published report titled “Uveitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” the company provides in-depth analysis of the market growth prospects for the eight-year assessment period, backing it up with historic and current market data.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3596

Company Profiles

  • Allergan, Inc.,
  • Bausch & Lomb Incorporated.
  • Novartis AG (Alcon Laboratories Inc.)
  • AbbVie Inc.
  • Santen Pharmaceutical Co., Ltd
  • Eyegate Pharmaceuticals, Inc.
  • Alimera Sciences, Inc.
  • pSivida Corp.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3596

Persistence Market Research identified a few important drivers and trends that will continue to present attractive growth opportunities during 2016-2024.

While surge in autoimmune disorders is identified to primarily generate the demand for uveitis, the market has been witnessing strong emergence of immunosuppressive therapies to treat uveitis since the past few years, which is expected to create a new set of opportunities for leading players in near future.

Some of the leading companies in the uveitis treatment marketplace have been investing in new, improved product launches since the past decade. While a significant number of uveitis drugs are already in the pipeline, increasing in-licensing approvals for new market entrants will boost the scope of treatment against uveitis, ultimately creating new lucrative opportunities,” states Persistence Market Research.

  • Increasing demand for generic drugs also prompt at an important trend in the global uveitis treatment market that will reportedly generate a range of opportunities for established as well as new pharma players.
  • In addition to growing R&D activities in the field of eye disorders, rising optometric clinical practice will also provide an impetus to market growth.
  • With surging uveitis prevalence, a host of biological drug development projects is anticipated to push the potential of the uveitis treatment market.
  • Moreover, growing prevalence of TB associated with intermediate uveitis will continue to push the opportunities in intermediate uveitis segment.
  • Another proliferating trend in uveitis treatment market includes increasing demand for local steroid implants, especially for non-infectious posterior uveitis.
  • As corticosteroid mono-therapy is no more considered the first line treatment for uveitis, the market has been witnessing introduction of various modified corticosteroid medication and drug delivery methods since the recent past.
  • Major players in the segment are working to add novel drugs to their product portfolio.
  • R&D in topical agents segment will also benefit the market growth in near future.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3596

Segmentation by treatment type:

  • Corticosteroids
  • Immunosuppressants
  • Monoclonal antibodies
  • Cycloplegic agents
  • Antibodies
  • Antivirals
  • Antifungals
  • Analgesics

Corticosteroids will remain the largest segment, followed by antibiotics and monoclonal antibodies. While corticosteroids segment is foreseen to account for a dominant market share of over 21% in 2024, antibiotics segment is expected to witness the fastest growth at a CAGR of 8% – reaching beyond US$ 146 Mn over 2016-2024. Monoclonal antibodies segment will also exhibit healthy growth at a CAGR of 7%, reaching revenues worth US$ 142.7 Mn by the end of 2024.

Segmentation by disease type:

  • Anterior uveitis
  • Posterior uveitis
  • Intermediate uveitis
  • Panuveitis

Anterior uveitis segment will continue to dominate. Through 2024, this segment will capture around 60% value share, representing a value of over US$ 500 Mn. Posterior uveitis is also estimated for a considerable market value share of over 23% in 2024. Attributed to increased prevalence of TB in intermediate uveitis, the intermediate uveitis will possibly be the second fastest growing segment over the forecast period.

Segmentation by cause:

  • Infectious
  • Non-infectious

On the basis of cause, infectious uveitis will remain the larger segment with over 87% share by 2024 end but non-infectious uveitis is predicted to witness a higher CAGR of 7.4% during the eight-year period.

Segmentation by distribution channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Drug stores

By distribution channel, hospital pharmacies segment will account for over 46% revenue share in 2024, whereas retail pharmacies segment is likely to capture around 30% share. Online pharmacies and drug stores segments will also witness healthy growth at over 6% CAGR during the aforementioned period.

Segmentation by region:

The report provides regional analysis that examines the global market classifying it into five key regions.

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East and Africa (MEA)

North America, the largest and fastest growing regional market for uveitis treatment globally, will retain its dominant position over the assessed period. With over 34% market value share in 2024, this regional will possibly account for around US$ 290 Mn. Europe will remain the second key market with nearly 27% share by the end of forecast period, followed by Asia Pacific.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

Kidney Dialysis Equipment Market To Grow At 6.5% Y-O-Y In Forecast Years 2024

Market Report Summary 

  • Market – Kidney Dialysis Equipment Market 
  • Market Value – US$ 25.128 Bn in 2024 
  • Market CAGR Value – 6.5% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

Persistence Market Research’s recent report on Global Market Study on Kidney Dialysis Equipment: Latin America Expected to Emerge the Third Attractive Regional Market  forecasts the market revenues to reach US$ 25.128 Bn by 2024 end. The US$ 15 Bn kidney dialysis market is projected to grow at a CAGR of 6.5% through 2024.

Increasing Prevalence of Chronic Kidney Disease and Adoption of Technologically Advanced Products Spurring Demand

The preponderance of chronic kidney disease (CKD), aggravated by geriatric population and rising life expectancy, will continue to spur the demand for hemodialysis therapy. Expanding ESRD patient pool is another factor influencing market growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/4487

Company Profiles

  • Fresenius Medical Care AG & Co. (KGaA Fresenius SE & Co. KGaA)
  • Baxter International, Inc.
  • Nipro Corporation
  • B. Braun Melsungen
  • Nikkiso Co, Ltd.
  • NxStage Medical, Inc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4487

Favorable government initiatives and rising healthcare funding to increase awareness about therapeutic modalities are also anticipated to boost equipment sales during the forecast period. The introduction of technologically advanced and user-friendly dialysis equipment and adoption of renal dialysis over kidney transplantation are key trends impacting the market.

“Manufacturers will discover lucrative opportunities in pediatric dialysis. In addition, rising demand for cost-effective equipment in low and middle-income countries will also present multiple revenue generation channels”.

– Analyst, Life Sciences & Transformational Health, Persistence Market Research

Asia Pacific will Remain at the Forefront of Global Demand for Kidney Dialysis Equipment

Asia Pacific will remain the largest and the fastest growing market for kidney dialysis equipment throughout the projected period. Valued at US$ 4.57 Bn currently, the market in APAC is foreseen to surpass US$ 9.0 Bn by the end of 2024, accounting for over 38% market value share. North America, Europe, and Latin America will be the other key markets globally. While APAC is expected to thrive at a CAGR of 9.9%, MEA, and Latin America will remain the other fast-growing markets globally.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/4487

By equipment type, hemodialysis equipment will continue to outsell peritoneal dialysis equipment during the assessed period.

  • Hemodialysis equipment will capture over 88% market share in 2016 but is anticipated to lose nearly 100 BPS over the next eight-year period.
  • Dialyzers are expected to witness the fastest growth during 2016-2024
  • Peritoneal dialysis segment will gain 100 BPS through 2024, reaching a market share of over 12% by 2024
  • Within peritoneal dialysis equipment segment, the peritoneal dialysis machine sub-segment will account for highest sales.

The end-user analysis by Persistence Market Research reflects the emergence of home-care settings as a critical end-user.

  • In-center dialysis segment will witness a slight decline in its revenue share; by 2024, this segment is projected to account for 85% share of the overall end-use segment
  • Demand for kidney dialysis equipment from home care settings will grow at a higher CAGR than in-center dialysis
  • Rapid adoption of home dialysis is indicative of a paradigm shift in end-use demand

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

Allergic Rhinitis Market To Witness A CAGR Of 7.5% Between 2024

Market Report Summary 

  • Market – Allergic Rhinitis Market 
  • Market Value – US$ 7,000 Mn in 2024 
  • Market CAGR Value – 7.5% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

“Technological advancements in the medical world and rising prevalence of foodborne diseases will primarily build the market for allergic rhinitis treatment globally. Secondarily, strategic partnerships and synergies between big brands, soaring usage of second-generation multiplex immunoassay, and augmenting R&D activities in life sciences and molecular diagnostics will support the market surge within the next few years.

Over 2016-2020, the global AR treatment market will reach US$ 14 Bn, which will further take a leap to US$ 16.038 Bn by the end of 2024. Over 2016-2024, the market is likely to see impressive growth at a healthy CAGR of 7.5%.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12154

Company Profiles

  • Merck & Co.
  • Boehringer Ingelheim
  • AstraZeneca
  • GlaxoSmithKline PLC
  • Sanofi S.A.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Alcon (Novartis AG)

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12154

– Market Research Expert, Life Sciences & Transformational Health, Persistence Market Research.

According to Persistence Market Research’s recent report titled “Global Allergic Rhinitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” key market competitors have embraced different strategic moves in order to strengthen their positions in the global allergic rhinitis treatment marketplace. These activities, according to Persistence Market Research, will boost the overall status of the market in near future.

  • Merck & Co. and Johnson & Johnson are concentrating on new product development, such as nasal sprays.
  • Boehringer Ingelheim will continue to contribute a major share to the market through an increased focus on R&D and a strong distribution network.
  • Sanofi S.A. is also focusing more on increasing R&D investments directed to expanded sales.
  • In addition to growing R&D efforts, AstraZeneca is also emphasizing on innovation of technologically advanced products and acquisition of selective regional players.
  • GlaxoSmithKline PLC and Alcon (Novartis AG) are prioritising cost-effective product development for long-term profits; Alcon specifically aims to tap into emerging markets.
  • Acquisition of players from the same segment and different region will be a key strategy of Teva Pharmaceutical Industries Ltd., which targets production capacity expansion.

By disease type, perennial AR segment will remain dominant with around 47% market value share in 2024, gaining around 123 BPS throughout the forecast period. On the other hand, despite losing over 30 BPS over 2016-2024, occupational AR will continue to be the second largest segment with over 35% revenue share at the end of the assessment period. While the revenues of the former are expected to surpass US$ 7.0 Bn, the latter will possibly exceed a value of US$ 5.0 Bn by the end of 2024.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12154

By treatment type, immunotherapy treatment segment is expected to be the fastest growing segment over the forecast owing to introduction of new immunotherapy based products, followed by antihistamines segment. However, antihistamines will continue to be the leading treatment type segment with over 50% share in 2024, followed by corticosteroids with over 31% share.

Based on route of administration, oral route of administration segment will cover nearly half of the market in terms of value, whereas nasal route of administration segment is anticipated to capture around 38% share of the total market value in 2024. Intravenous segment is foreseen to witness a higher CAGR compared to others, which can uplift the sales revenues of this segment to cross US$ 1.25 Bn in 2024.

On the basis of distribution channel, retail pharmacies will account for higher revenues than hospital pharmacies throughout the assessed period. Retail pharmacy revenues are likely to surpass US$ 7.0 Bn, growing at the fastest CAGR of 3.9% over 2016-2024. Whereas, hospital pharmacies will reach over US$ 5.0 Bn, accounting for around 31% share of the market value in 2024.

As per the geographical assessment of the global allergic rhinitis treatment market, North America will continue to capture the maximum revenue share over the 10-year tenure. With over 63% value share by 2024-end, this region is likely to surpass US$ 10.0 Bn in terms of revenues. European market will possibly attract the revenues worth US$ 3.68 Bn by 2024 end, contributing over 22% share of the market size. The third key region i.e. APAC is estimated to reach over US$ 1.27 Bn in 2024.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

Call For Inorganic Expansion To Record A CAGR Of 6% In The Cell Free Protein Expression Market Between 2024

Market Report Summary 

  • Market – Cell Free Protein Expression Market 
  • Market Value – US$ 268.4 Million in 2024 
  • Market CAGR Value – 6% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

Persistence Market Research (PMR) delivers key insights on the global cell free protein expression market in its upcoming report titled, “Cell Free Protein Expression Market: Global Industry Analysis and Forecast, 2016–2024”. In terms of revenue, the global cell free protein expression market is projected to register a CAGR of 6.0% over the forecast period owing to various factors, on which PMR offers detailed insights and forecasts.

Global cell free protein expression market dynamics

The primary factors fuelling demand for cell free protein expression market are increasing R&D outsourcing by pharmaceutical and biotechnological companies, declining R&D productivity and patent cliff sales drop leading to increasing research intensity in the pharmaceutical sector and increasing expenditure on biosimilar development.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12385

Company Profiles 

  • New England Biolabs
  • GeneCopoeia, Inc.
  • Takara Bio Company
  • CellFree Sciences Co.,Ltd.
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Bioneer corporation
  • Cube biotech
  • biotechrabbit GmbH
  • Jena Bioscience GmbH

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12385

Other factors driving cell free protein expression market are a growing demand for simple and efficient protein production methods, contamination free approach and increasing focus on production of mammalian cell free lysate due to drug discovery.

One of the major bottleneck in the cell free protein expression market is the low protein production volumes in the process. This limitation makes cell free protein expression unsuitable for large industrial applications and is generally preferred in small R&D processes. However, efforts are being made to overcome this constraint and make it a preferred expression system in industrial settings.

Global cell free protein expression market forecast

The market is segmented based on product type, application, expression mode, end users, and region. Based on product type, the market has been segmented into E. coli cell-free protein expression system, rabbit reticulocytes cell-free protein expression system, wheat germ cell-free protein expression system, insect cells cell-free protein expression system, mammalian cell-free protein expression system, and consumables (labelling tags, vectors).

Mammalian cell-free protein expression system segment is expected to grow with the fastest CAGR over the forecast period, owing to increasing usage of mammalian cell lysate in humanized proteomic and biologics study. The segment is expected to register a significant CAGR of 6.0% during the forecast period.

Wheat germ cell-free protein expression system is also anticipated to witness a CAGR of 5.8% over the forecast period. The rapidly increasing demand for simpler, rapid and efficient protein production methods is boosting the cell-free protein expression market in research and development field.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12385

The market has been segmented based on major applications such as enzyme engineering, protein labelling, protein-protein interaction, and protein purification. The protein-protein interaction segment is expected to register the highest CAGR of 6.0% over the forecast period due to increasing number of proteomic studies. The simple presentation of cell-free protein expression system makes it easier to integrate them into high throughput platforms for efficient biologics and proteomics studies.

Cell-free protein expression systems allow protein screening without necessitating a gene-cloning step thus enabling an accelerated process/product development pipelines which makes up for attractive opportunity for market players.

Based on end users, the market has been segmented into biotechnological companies, pharmaceutical companies, contract research organizations, and academic/research institutes.  The academic/research institutes is anticipated to account for the highest market share over the forecast period, registering a CAGR of 6.1% due to vast research applications in the protein libraries generation for functional genomic studies, customized drug development studies, and the expression of virus-like particles, among many other applications.

This report assesses trends, that drive growth of each segment on the global as well as regional levels, and offers potential takeaways, that could prove substantially useful to biopharmaceutical manufacturing companies who wish to enter into the cell free protein expression market.

North America and Europe are expected to dominate the cell free protein expression market with maximum market share in 2016. North America and Europe collectively, are expected to account for more than 65% of the total cell free protein expression market share in terms of value in 2016. Among emerging markets, Asia Pacific is estimated to exhibit the highest CAGR of 6.1% over the forecast period, due to increase in the research and development expenditure in the region.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

The Medical Implants Sterile Packaging Market To Display Growth In Revenue By 6.5% Between 2024

Market Report Summary 

  • Market – Medical Implants Sterile Packaging Market 
  • Market Value – US$ 2,436.4 Mn in 2024 
  • Market CAGR Value – 6.5% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

According to a new report by Persistence Market Research titled “Medical Implants Sterile Packaging Market: Global Industry Analysis and Forecast, 2016–2024”, the global medical implants sterile packaging market is anticipated to be valued at US$ 1,427.8 Mn by the end of 2016 and this is estimated to increase to US$ 2,436.4 Mn by the end of 2024, registering a CAGR of 6.5% in terms of value during the forecast period (2016 – 2024). Orthopedic implants (including spinal implants, reconstructive joint implants, and extremity braces & support) is expected to gain a significant market share owing to a large global baby boomer population prone to orthopedic ailments.

Global medical implants sterile packaging market dynamics

A growing demand in medical packaging and increasing usage of hygiene packaging among multiple end users is anticipated to drive advances in the industry. Medical implants sterile packaging is one of the emerging packaging solutions, widely used for pharma packaging, and is driven by factors such as increasing implant surgeries, innovative medical equipment and implants, increasing chronic degenerative diseases, and changing lifestyle of people.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12379

Companies Profiles

  • Oliver Tolas
  • Bemis Company, Inc
  • Steripack Contract Manufacturing
  • Orchid Orthopedic Solutions LLC
  • Multivac Group.
  • Janco Inc
  • Sealed Air Corporation

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12379

Global medical implants sterile packaging market forecast

The global medical implants sterile packaging market report is categorically split into four sections – based on product type, material type, application, and region. On the basis of product type the global medical implants sterile packaging market has been segmented into pouches & bags, blister, clamshell, tubes, vials, and others. On the basis of material, the global medical implants sterile packaging market has been segmented into plastic, foils, paper, and others.

On the basis of application, the global medical implants sterile packaging market has been segmented into spinal implants, extremity braces & support, dental implants, cardiovascular implants, reconstructive joint implants, and other implants. On the basis of region, the global medical implants sterile packaging market has been segmented into the five key regions of North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

The pouches & bags product type is likely to emerge the dominant segment throughout the forecast period due to its wide application in multiple pharma industries. The pouches & bags product type segment is estimated to create a large market share of 53.1% in 2016 and is expected to expand at a CAGR of 6.9% from 2016 to 2024 in terms of value.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12379

The clamshell product type segment is anticipated to witness high Y-o-Y growth rates ranging from 5.8% to 7.2% over 2016–2024 and is expected to exhibit a CAGR of 7.6% in terms of value over the forecast period.

The foils material type segment is expected to create a significant CAGR of 7.3% in terms of value over the forecast period. The paper material type segment is projected to grow at lower Y-o-Y rates ranging from 5.6% to 5.7% over 2016–2024.

The dental implants application segment is estimated to account for 13.7% market share by 2016 end and is anticipated to remain stagnant at 13.8% during the forecast period. The cardiovascular implants segment is projected to grow at a CAGR of 7% in terms of value during 2016–2024.

Among regions, Asia Pacific is anticipated to be the key region driving overall demand for medical implants sterile packaging owing to the increasing usage of packaging and growing consumer spending power in the region. Mature markets such as North America and Europe are expected to witness uneven growth while Latin America and MEA are expected to register sluggish growth throughout the forecast period.

Europe is anticipated to witness higher Y-o-Y growth rates ranging from 5.9% to 6.2% over 2016–2024, and is estimated to record 7.3% CAGR in terms of value over the forecast period.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

Hepatitis C Treatment Market To Register CAGR 13.1% Growth In Revenue Between 2024

Market Report Summary 

  • Market – Hepatitis C Treatment Market 
  • Market Value – US$ 71.13 Bn in 2024 
  • Market CAGR Value – 13.1% in 2024 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

Persistence Market Research (PMR) delivers key insights on the global hepatitis C treatment market in its latest report titled “Hepatitis C Treatment Market: Global Industry Analysis and Forecast, 2016–2024”. The global hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a CAGR of 13.1% over the forecast period. 

Market dynamics

Growth of the global hepatitis C treatment market is primarily driven by factors such as increase in the prevalence of hepatitis C infections in the U.S. and Canada and rising per capita healthcare expenditure across the globe. Also government initiatives to control infection and various private NGOs creating awareness about treatment is also fueling the market growth.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3602

Company Profiles

  • Gilead Sciences, Inc.
  • AbbVie Inc.
  • Kadmon Holdings, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Johnson & Johnson

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3602

However, high cost associated with hepatitis C treatment drugs and lack of awareness about hepatitis C infection in the regions of Asia Pacific, Middle East and Africa, and Latin America is expected to impede growth of the global hepatitis C treatment market.

Market forecast

By drug class, the market is segmented into HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral which is again sub-divided into various drugs sub segments. The combination segment is expected to contribute a maximum share to the global hepatitis C treatment market and register the fastest CAGR of 13.9% during the forecast period.

By distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Among these, the hospital pharmacies segment is anticipated to be dominant throughout the forecast period and is projected to account for about 43.7% share of the total global hepatitis C treatment market revenue by 2024.

The hospital pharmacies segment is anticipated to emerge as the most attractive segment in the global hepatitis C treatment market owing to growing instances of hospitalization and improved accessibility and services. The online pharmacies segment is expected to register the fastest CAGR during the forecast period and is estimated to create absolute $ opportunity of US$ 713.8 Mn in 2017 over 2016.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3602

The online pharmacies segment is expected to witness significant growth during the forecast period and this can be attributed to high availability of hepatitis C treatment drugs and discounts provided by online pharmacies.

This report covers global and regional trends along with an analysis of the market potential. North America is estimated to account for 45% share in the global hepatitis C treatment market by 2016, whereas Asia Pacific is projected to grow at a healthy CAGR of 14.8% due to increasing awareness about hepatitis C infections. Europe region is expected to account for 19.6% share in the global hepatitis C treatment market by 2016 end.

Latin America was valued at US$ 2,915.8 Mn in 2015 and is estimated to reach US$ 3,311.1 Mn by 2016, with a Y-o-Y growth of 13.6% over 2015–2016. The Middle East and Africa region was valued at US$ 1,792.5 Mn in 2015 and is estimated to reach US$ 1,988.1 Mn by 2016.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

 

Categories
Coronavirus News

The Animal Parasiticide Market To Go Strong With 5.9% CAGR Between 2026

Market Report Summary 

  • Market – Animal Parasiticide Market 
  • Market Value – US$ 13,064.7 Mn in 2026 
  • Market CAGR Value – 5.9% in 2026 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

In this report, Persistence Market Research  (PMR) delivers key insights on the global animal parasiticides market in its published report, titled “Animal Parasiticides Market: Global Industry Analysis and Forecast, 2016–2026.” In terms of revenue, the global animal parasiticides market is estimated to register a promising CAGR of 5.9% over the forecast period, owing to numerous factors, about which PMR offers thorough insights and forecasts in this report. The global animal parasiticides market registered a value of US$ 6,976.2 Mn in 2015 and is anticipated to reach a market valuation of US$ 13,064.7 Mn by 2026.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/7996

Company Profile

  • Sanofi S.A. (Merial)
  • Ceva Sante Animlae
  • Virbac SA
  • Vetoquinol S.A.
  • Eli Lilly and Company
  • Zoetis Inc.
  • Merck & Co Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Perrigo Co. plc

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/7996

Market dynamics

The prime factors powering the demand for animal parasiticides are increasing awareness about animal healthcare, increasing demand of animal derived food products, growing concern about foodborne diseases and zoonotic diseases, growth in adoption of companion animals and increase in animal healthcare expenditure. However, a growing preference for vegetarian food and diet and a stringent approval process for animal parasiticides coupled with restrictions on the use of parasiticides in food producing animals are the restraints affecting the global animal parasiticides market.

A key trend defining the market is that larger players are focused towards enhancing their geographical presence and expanding their customer base by entering into strategic mergers and acquisitions. Furthermore, huge investment from government organizations and private players for research and development activities is also a key trend of global animal parasiticides market.

Market forecast

The market is segmented based on product type, animal type, distribution channel and region. Based on product type, the market is sub-segmented into Ectoparasiticides, Endoparasiticides and Endectocides. Among the product type segment, Endoparasiticides segment is expected to exhibit the highest revenue growth over the forecast period. The Endoparasiticides product type segment is expected to register a significant CAGR of 5.9% during the forecast period in terms of value. The Ectoparasiticides segment is projected to exhibit a CAGR of 5.7% over the forecast period in terms of value.

The market has also been segmented by animal type into food producing animals and companion animals. The food producing animals segment is expected to be the largest over the forecast period, with the segment witnessing a CAGR of 6.2% during the forecast period. One of the key growth drivers for animal parasiticides market is the growing concern about foodborne and zoonotic diseases.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/7996

This report assesses trends driving growth of each segment on the regional as well as country level and offers potential takeaways that could prove substantially useful to animal parasiticides manufacturers looking to enter the market. Western Europe market has been estimated to dominate the global animal parasiticides market, accounting for a maximum revenue share of the market by 2016 end.

North America is expected to account for over 20.0% revenue share of the global animal parasiticides market by 2016 end. Among the emerging markets, APEJ is estimated to exhibit a significant CAGR of 6.4% over the forecast period, followed by the North America market, due to increasing awareness about animal healthcare and increasing demand for animal derived food products.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com